-
French court adjourns trial over 2020 death of delivery driver
-
S.Africa ambassador calls for talks with US over 'tense' ties
-
Serbian student movement eyes power after election triumph
-
'Smells of freedom': Serbians hopeful after landmark election
-
Machado ready to meet Venezuela leader after shock return
-
South Africa select 'enforcer' Coetzee for Australia decider
-
Lula celebrates election win as Brazil markets tumble
-
Botanists comb Gabon's rich rainforests with nature on the line
-
France's Macron accuses social media of sowing discord ahead of election
-
New levy on non-EU parcels kicks in Sunday
-
Anthropic unveils IPO filing showing soaring sales and AI risks
-
Stocks climb ahead of tech earnings, central bank calls
-
US singer Chris Brown avoids jail over London nightclub brawl
-
Part of London's Oxford Street pedestrianised 'forever'
-
US singer Chris Brown avoids jail over UK nightclub brawl
-
Canadian youth seek climate action in landmark trial
-
Man Utd crisis deepens as Carrick faces axe
-
Trump blasts Norway over Nobel Peace Prize snub
-
Serbian student movement eyes power after resounding snap poll victory
-
Japan PM vows swift response to wave of cyberattacks
-
Eala breezes past world number 411 in Tokyo opener
-
Stocks mostly rise before tech earnings, central bank calls
-
Swedish Centre Party leader says government coalition talks failed
-
France's Macron to visit Marseille after protest violence
-
Barca's big-game defeats pose familiar questions
-
German union slams Audi boss's appearance at Trump rally
-
Russia says open to mini Ukraine ceasefires, but no let up in war
-
UK set for 'limited' budget giveaways as borrowing costs surge
-
Bangladesh measles crisis 'warning sign' of other outbreaks: report
-
Anthropic's AI model accessed US voter data: Axios
-
'Historic victory': World leaders celebrate Lula's re-election
-
Malaysia's Johor reopens schools as haze eases
-
Stock markets mixed ahead of tech earnings, central bank decisions
-
Carragher says Fernandes benching was intended as public punishment
-
الظفرة يطلب كشف تفاصيل قرار ركلة الإقصاء أمام خورفكان
-
Mother renews anti-bullying appeal a decade after son’s death
-
Canada-EU summit seeks deepened alliance as US ties fray
-
'Historic victory': Leftist leaders in the Americas celebrate Lula's re-election
-
Senegal to host Youth Games, Africa's first ever Olympics
-
African players in Europe: Jackson brace ends City's perfect record
-
ITV drama Adultery examines temptation, class and family consequences
-
طرق دبي تفتتح الجمعة الجسر الأخير في مشروع دوار المركز التجاري
-
Argentine police arrest stepfather after pregnant 10-year-old reaches hospital
-
نقل رالي دكار 2027 من السعودية في قرار استثنائي
-
New levy on non-EU parcels kicks in November 1
-
Mother dies after rescuing sons from riptide in the Bahamas
-
Saudi coalition says struck Houthi missile facilities after Riyadh airport attack
-
James Blunt reportedly sought extra underwear during Celebrity Traitors filming
-
مهرجان الظفرة الرابع يختتم منافسات الهجن بتتويج الفائزين
-
Manchester United stand-in captain calls for change after Bournemouth loss
US pharmacy chains to pay $10 bn to settle opioid cases
US pharmacy chains CVS Health and Walgreens said Wednesday they had reached preliminary agreements to together pay more than $10 billion to resolve opioid claims from US states, cities and tribes.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims as well as cities, counties and states.
The pharmacies' agreements in principal are for much bigger sums than previously agreed by pharmacy chains, putting that sector in the same ballpark as drugmakers like Teva and Johnson & Johnson and distributors like AmerisourceBergen and McKesson that have previously reached multi-billion dollar agreements.
"We are pleased to resolve these longstanding claims and putting them behind us is in the best interest of all parties, as well as our customers, colleagues and shareholders," CVS chief policy officer Thomas Moriarty said in a statement.
"As one of the largest pharmacy chains in the nation, we remain committed to being a part of the solution," Walgreens said. "We believe this is in the best interest of the company and our stakeholders at this time."
Lawsuits against the retail chains have alleged the drugstores didn't do enough to root out the deluge of opioids that have ravaged communities across the United States.
The stores have argued they are not responsible for the crisis and that the health care system relies on pharmacies to fill legitimate prescriptions.
CVS and Walgreens each said the settlements include "no admission of wrongdoing or liability" by the companies.
The agreements announced Wednesday are contingent on sufficient approvals by counties, states, tribes and other political subdivisions and do not cover lawsuits involving private litigants.
Bloomberg News reported that Walmart also reached a tentative agreement involving billions of dollars. A Walmart spokesman declined comment.
CVS said its agreement will involve paying $5 billion to states, political subdivisions and tribes over the next 10 years, beginning in 2023.
CVS Chief Executive Karen Lynch told an earnings call that the company recognizes "the seriousness of the opioid abuse misconduct has had on so many Americans."
Walgreens plans payments of about $4.8 billion over 15 years to settling states, plus $144.5 million to Native American tribes over the same period and $753.5 million in attorney's fees over six years.
Both companies signaled they would continue to fight other lawsuits.
"The company will continue to vigorously defend against any litigation not covered by the Settlement Frameworks, including private plaintiff litigation. The Company continues to believe it has strong legal defenses and appellate arguments in all of these cases," said Walgreens.
- Multiple lawsuits -
CVS earlier this year announced an agreement to pay $484 million to the state of Florida to settle opioid claims, with the money set to fund treatments for drug misuse and health effects of the crisis.
The chain, along with Walgreens, Rite Aid and Walmart, agreed last summer to a $26 million settlement with two counties in New York state.
And an Ohio jury last November sided with two of the state's counties that sued Walmart, Walgreens and CVS, determining the three companies acted illegally in filling significant opioid prescriptions, creating an "oversupply" of the drugs and a "public nuisance."
For many people, opioid addiction begins with prescribed pain pills, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Opioid victims and their families addressed the Sackler family, owners of Purdue Pharma, the maker of OxyContin, directly in a US courtroom in March as part of the company's bankruptcy case.
"We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons, who died at ages 32 and 25 after years of dealing with opioid addictions.
"Two boys are gone because of your 'safe' medication," Fitzgerald said.
U.Shaheen--SF-PST